Updated:
Clover Vitality
Clover Vitality is a growth equity firm focused exclusively on emerging food and beverage companies. They support entrepreneurs throughout their journey,...
Clover Vitality
Clover Vitality is a growth equity firm focused exclusively on emerging food and beverage companies. They support entrepreneurs throughout their journey, drawing from experiences as investors and operators and utilizing an extensive network in the industry. They invest in companies whose growth trajectory requires capital and resources that often exceed the capabilities of angels, typically when companies are generating $500K-$10M in revenue and experiencing rapid growth.
General information
Firm type
Private Equity
Year founded
2021
Location
Region
North America
Country
United States
City
Evanston
Corporate office
Evanston, IL, United States
Principals
Bert Cohen
Alex Schneider
David Choe
Sector focus
Frequently asked questions
What is Clover Vitality's investment strategy?
Clover Vitality pursues early-stage and growth equity investments in healthcare technology companies. The firm focuses on AI and machine learning applications that improve clinical workflows, diagnostic accuracy, and healthcare operations. It targets companies with existing US commercial traction, structuring direct equity investments rather than fund-of-funds commitments.
Where does Clover Vitality source its investments?
The firm's Evanston, Illinois headquarters positions it near major Midwestern academic medical centers and health systems, which can serve as pilot sites and early adopters for health-tech companies. This geographic base offers a sourcing channel distinct from coastal venture hubs. Specific sourcing partnerships or deal origination methods have not been publicly detailed.
What investment stages does Clover Vitality target?
Clover Vitality targets early-stage venture rounds through growth equity. The firm seeks companies that have moved beyond concept validation and are demonstrating commercial uptake, fitting the profile of a manager providing expansion capital to health-tech platforms.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: